Vaccine Efficacy Calculator
Calculate the percentage reduction in disease incidence among vaccinated individuals.
Understanding How Vaccine Efficacy Rates are Calculated
Vaccine efficacy (VE) is a critical metric used during clinical trials to determine how well a vaccine prevents a specific disease. It measures the proportionate reduction in cases among people who received the vaccine compared to those who did not.
The Vaccine Efficacy Formula
To calculate vaccine efficacy, researchers look at the "attack rate" (incidence) of the disease in both the vaccinated and the placebo groups. The standard formula used by health organizations like the CDC and WHO is:
Where:
- ARU (Attack Rate in Unvaccinated): Number of cases in the placebo group divided by the total number of people in the placebo group.
- ARV (Attack Rate in Vaccinated): Number of cases in the vaccine group divided by the total number of people in the vaccine group.
Step-by-Step Calculation Example
Imagine a clinical trial with 30,000 participants. They are split into two groups of 15,000 each.
- Placebo Group: 15,000 people, 100 cases of infection occur.
ARU = 100 / 15,000 = 0.00667 - Vaccine Group: 15,000 people, 5 cases of infection occur.
ARV = 5 / 15,000 = 0.00033
Now apply the formula:
VE = ((0.00667 – 0.00033) / 0.00667) × 100 = 95%
This result means that there was a 95% reduction in the risk of disease among the vaccinated group compared to the unvaccinated group during the trial period.
Efficacy vs. Effectiveness: What is the Difference?
While often used interchangeably, these terms have distinct meanings in science:
- Efficacy: Refers to how the vaccine performs in ideal, controlled conditions (like a Phase III clinical trial).
- Effectiveness: Refers to how the vaccine performs in the "real world" where conditions are not controlled, and the population is much more diverse.
Factors That Influence Results
Several variables can impact the calculated efficacy rate, including the variants of the pathogen circulating during the trial, the time elapsed since vaccination, the age of the participants, and the specific "endpoint" being measured (e.g., preventing any infection versus preventing severe hospitalization).